France · Source-listed medicine information

France / CIS 64493883

BEXSERO suspension injectable en seringue préremplie. Vaccin méningococcique groupe B (ADNr, composant, adsorbé)

suspension injectable · intramusculaire

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsuspension injectable
Routeintramusculaire
Ingredient entries4
CountryFrance

Product identity

At a glance

Authorisation holder
GSK VACCINES SRL (ITALIE)
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 64493883

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for BEXSERO suspension injectable en seringue préremplie. Vaccin méningococcique groupe B (ADNr, composant, adsorbé)
IngredientStrength / referenceSource role
PROTÉINE DE FUSION RECOMBINANTE NHBA DE NEISSERIA MENINGITIDIS GROUPE B suspension50 microgrammes0,50 mlSAGroup 1
PROTÉINE RECOMBINANTE NADA DE NEISSERIA MENINGITIDIS GROUPE B suspension50 microgrammes0,50 mlSAGroup 2
PROTÉINE DE FUSION RECOMBINANTE FHBP DE NEISSERIA MENINGITIDIS GROUPE B suspension50 microgrammes0,50 mlSAGroup 3
VÉSICULES DE MEMBRANE EXTERNE (OMV) DE NEISSERIA MENINGITIDIS GROUPE B suspension25 microgrammes0,50 mlSAGroup 4

Pack references

Presentations (1)

1 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s)

CIP13 3400926863036

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 64493883 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →